Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)

EGX:SIPC Income Statement

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	22.78	13.31	18.2	45.42	69.76
Revenue Growth (YoY)	71.17%	-26.88%	-59.93%	-34.89%	3.60%
Cost of Revenue	19.94	3.51	10.89	26.67	30.03
Gross Profit	2.84	9.8	7.31	18.75	39.73
Selling, General & Admin	6.29	6.48	5.72	9.85	19.25
Other Operating Expenses	0.99	-0.04	-	-	-
Operating Expenses	13.7	6.45	5.73	9.9	19.5
Operating Income	-10.86	3.34	1.58	8.85	20.23
Interest Expense	-1.2	-1.05	-1.07	-0.65	-0.66
Currency Exchange Gain (Loss)	-8.66	-0.62	0	-	-
Other Non Operating Income (Expenses)	2.12	0.5	0.44	0.62	-
Pretax Income	-18.61	2.18	0.96	8.81	19.56
Income Tax Expense	-0.57	1.02	0.94	2.03	4.42
Net Income	-18.04	1.16	0.02	6.78	15.14
Preferred Dividends & Other Adjustments	-	0.12	0	1.29	3.11
Net Income to Common	-18.04	1.04	0.01	5.49	12.04
Net Income Growth	-	6280.77%	-99.73%	-55.22%	76.28%
Shares Outstanding (Basic)	250	250	250	250	-
Shares Outstanding (Diluted)	250	250	250	250	-
EPS (Basic)	-0.07	0.00	0.00	0.02	-
EPS (Diluted)	-0.07	0.00	0.00	0.02	-
EPS Growth	-	7075.86%	-99.74%	-	-
Free Cash Flow	-2.08	2.09	-17.29	3.44	-15.25
Free Cash Flow Per Share	-0.01	0.01	-0.07	0.01	-
Gross Margin	12.47%	73.63%	40.17%	41.28%	56.95%
Operating Margin	-47.68%	25.13%	8.70%	19.48%	29.00%
Profit Margin	-79.19%	7.82%	0.08%	12.09%	17.26%
Free Cash Flow Margin	-9.14%	15.72%	-94.97%	7.57%	-21.86%
EBITDA	-7.77	6.56	5.4	12.06	22.6
EBITDA Margin	-34.10%	49.31%	29.68%	26.55%	32.40%
D&A For EBITDA	3.09	3.22	3.82	3.21	2.38
EBIT	-10.86	3.34	1.58	8.85	20.23
EBIT Margin	-47.68%	25.13%	8.70%	19.48%	29.00%
Effective Tax Rate	-	46.88%	98.11%	23.04%	22.60%
Advertising Expenses	0	0	0.03	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.